Pneuma Respiratory

About:

Pneuma Respiratory is a pharmaceutical company that creates digital solutions for respiratory drug delivery.

Website: https://pneumarespiratory.com/

Twitter/X: pneumaplatform

Top Investors: Haisco

Description:

Pneuma Respiratory is a pharmaceutical company that creates digital solutions for respiratory drug delivery. It has created PNEUMAHALER, the first fully integrated digital breath activated inhaler. The inhaled delivery system has integrated Bluetooth technology to provide feedback on drug delivery to patients, family members and health care providers. Using Pneuma's digital droplet ejector technology, Pneuma's device, although currently available for investigational purposes only, has the potential to ultimately deliver a spectrum of novel therapies, including biologics, through the lungs. Pneuma Respiratory was founded in 2015 and is headquartered in Boone, North Carolina, United States.

Total Funding Amount:

$23.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boone, North Carolina, United States

Founded Date:

2015-01-01

Founders:

Eric Hunter

Number of Employees:

11-50

Last Funding Date:

2021-11-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai